Hydrocortisone
| Cortisol | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 362.50 g/mol [1] |
| Appearance | Plates from alc or iso-propyl alc [1] |
| Odor | Odorless [1] |
| Taste | Bitter taste [1] |
| Melting point | 220 °C [1] |
| Solubility | 320 mg/L (at 25 °C) [1] |
| Predicted LogP | 1.6 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C21H30O5 |
| IUPAC name | (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one |
| SMILES | C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O |
| InChI | InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1 |
| InChIKey | JYGXADMDTFJGBT-VWUMJDOOSA-N |
| CAS number | 50-23-7 |
| UNII | WI4X0X7BPJ |
| PubChem CID | 5754 |
| Pharmacokinetics[] | |
|---|---|
| Onset | Oral: 1.2 ± 0.4 hours (T<sub>max</sub>) |
| Elimination half-life | 1.2–2.0 hours[3][4] |
| Duration of action | 8–12 hours |
| Metabolism | 11β-Hydroxysteroid dehydrogenases, others |
| Excretion | Urine: >90% (<1% unchanged) |
| Routes of administration | By mouth, intravenous, topical, rectal |
Hydrocortisone (also known as Acticort, Cetacort, Hydrocortisyl, Cobadex, Hytone, Cortenema, Dermacort, Proctocort, Tarcortin or Cort-Dome) is a substance of the steroid class.
Chemistry
Stereochemistry []
Hydrocortisone is a single defined stereoisomer.
Druglikeness
Lipinski's rule of five
Hydrocortisone matches Lipinski's rule of five.Pharmacology
ATC Classification
- alimentary tract and metabolism (A)
- stomatological preparations (A01)
- stomatological preparations (A01A)
- corticosteroids for local oral treatment (A01AC)
- hydrocortisone (A01AC03)
- antidiarrheals, intestinal antiinflammatory/antiinfective agents (A07)
- intestinal antiinflammatory agents (A07E)
- corticosteroids acting locally (A07EA)
- hydrocortisone (A07EA02)
- cardiovascular system (C)
- vasoprotectives (C05)
- agents for treatment of hemorrhoids and anal fissures for topical use (C05A)
- corticosteroids (C05AA)
- hydrocortisone (C05AA01)
- dermatologicals (D)
- corticosteroids, dermatological preparations (D07)
- corticosteroids, plain (D07A)
- corticosteroids, weak (group i) (D07AA)
- (D07AA02)
- hydrocortisone (D07AA02)
- (D07AA02; A07EA02; H02AB09; S01BA02)
- corticosteroids, other combinations (D07X)
- corticosteroids, weak, other combinations (D07XA)
- hydrocortisone (D07XA01)
- systemic hormonal preparations, excl. sex hormones and insulins (H)
- corticosteroids for systemic use (H02)
- corticosteroids for systemic use, plain (H02A)
- glucocorticoids (H02AB)
- hydrocortisone (H02AB09)
- sensory organs (S)
- ophthalmologicals (S01)
- antiinflammatory agents (S01B)
- corticosteroids, plain (S01BA)
- hydrocortisone (S01BA02)
- antiinflammatory agents and antiinfectives in combination (S01C)
- corticosteroids/antiinfectives/mydriatics in combination (S01CB)
- hydrocortisone (S01CB03)
- otologicals (S02)
- corticosteroids (S02B)
- corticosteroids (S02BA)
- hydrocortisone (S02BA01)
MeSH Classification
- anti-inflammatory agents (M0001333)
Mechanism of action []
The short-term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation. Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days. Glucocorticoids inhibit neutrophil apoptosis and demargination; they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives; they inhibit NF-Kappa B and other inflammatory transcription factors; they promote anti-inflammatory genes like interleukin-10. Lower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive. High doses of glucocorticoids for an extended period bind to the mineralocorticoid receptor, raising sodium levels and decreasing potassium levels. [1]
Interactions []
Medical side effects []
214 side effects listed on drug labels in SIDER 4.1 (cortisol).
- Inflammation
- Eczema
- Pruritus
- Application site pain
- Application site burn
- Gastrointestinal disorder
- Unspecified disorder of intestine
- Fungal infection
- Pain
- Dry skin
- Skin burning sensation
- Dermatitis
- Rash
- Dermatitis perioral
- Erythema
- Redness
- Erythema facial
- Application site folliculitis
- Telangiectasia
- Acne
- Skin discolouration
- Skin depigmentation
- Acne infantile
- Eruption
- Application site irritation
- Abdominal distension
- Abdominal pain
- Gastrointestinal pain
- Abscess
- Pancreatitis acute
- Amenorrhoea
- Anaphylactic shock
- Anaphylactoid reaction
- Angioedema
- Decreased appetite
- Anxiety
- Arachnoiditis
- Arrhythmia
- Mental disorder
- Hypertrophic cardiomyopathy
- Infection
- Secondary infection
- Connective tissue disorder
- Contusion
- Delusion
- Diabetes mellitus
- Diabetic
- Diarrhoea
- Dizziness
- Syncope
- Dyspepsia
- Ecchymosis
- Oedema
- Fat embolism
- Endocrine disorder
- Epilepsy
- Oesophagitis
- Exophthalmos
- Eye disorder
- Asthenia
- Fatigue
- Body temperature increased
- Folliculitis
- Multiple fractures
- Fracture
- Gastroenteritis
- Glaucoma
- Glycosuria
- Hallucination
- Headache
- Cardiac arrest
- Cardiomegaly
- Cardiac failure
- Cardiac failure congestive
- Myocardial rupture
- Haemorrhage
- Haemoglobin
- Hepatomegaly
- Herpes virus infection
- Hiccups
- Hirsutism
- Hypernatraemia
- Hypersensitivity
- Hypertension
- Hypertrichosis
- Hypokalaemia
- Hypotension
- Immune system disorder
- Irritability
- Arthropathy
- Osteoarthritis
- Lethargy
- Leukocytosis
- Meningitis
- Miliaria
- Myocardial infarction
- Acute coronary syndrome
- Nausea
- Necrosis
- Nervous system disorder
- Neuritis
- Neuropathy peripheral
- Neuropathy
- Opportunistic infection
- Osteonecrosis
- Aseptic necrosis
- Osteoporosis
- Pancreatitis
- Optic neuritis
- Papilloedema
- Paraplegia
- Monoplegia
- Diplegia
- Paraesthesia
- Tingling sensation
- Peptic ulcer
- Petechiae
- Prurigo
- Mass
- Benign intracranial hypertension
- Psychotic disorder
- Pulmonary oedema
- Schizophrenia
- Convulsion
- Shock
- Skin infection
- Gastric ulcer
- Loss of consciousness
- Tachycardia
- Embolism
- Embolism venous
- Thrombophlebitis
- Tooth erosion
- Upper respiratory tract infection
- Urticaria
- Vasculitis
- Vertigo
- Viral infection
- Vomiting
- Weight increased
- Weight decreased
- Injury
- Alkalosis hypokalaemic
- Mood swings
- Affect lability
- Cataract
- Drug withdrawal syndrome
- Adrenocortical insufficiency acute
- Application site reaction
- Skin atrophy
- Growth retardation
- Impaired healing
- Intracranial pressure increased
- Muscular weakness
- Alanine aminotransferase increased
- Tendon rupture
- Oesophageal ulcer
- Skin irritation
- Joint swelling
- Skin striae
- Menstruation irregular
- Malnutrition
- Dermatitis contact
- Skin hyperpigmentation
- Leukoderma
- Dermatitis acneiform
- Skin disorder
- Paraparesis
- Malaise
- Discomfort
- Feeling abnormal
- Ill-defined disorder
- Myalgia
- Musculoskeletal discomfort
- Increased appetite
- Abdominal pain upper
- Bladder dysfunction
- Intraocular pressure increased
- Euphoric mood
- Cataract subcapsular
- Increased insulin requirement
- Steroid withdrawal syndrome
- Oesophageal candidiasis
- Muscle mass
- Personality change
- Spinal compression fracture
- Rectal haemorrhage
- Pancreatitis haemorrhagic
- Fluid retention
- Water retention
- Myopathy
- Proximal myopathy
- Glucose tolerance impaired
- Secondary adrenocortical insufficiency
- Drug dependence
- Dry eye
- Cushingoid
- Atrophy
- Cognitive disorder
- Mania
- Scleral thinning
- Skin exfoliation
- Rash maculo-papular
- Suicidal ideation
- Bradycardia
- Blindness
- Carbohydrate tolerance decreased
- Hyperhidrosis
- Infestation
- Nitrogen balance negative
- Electrolyte imbalance
- Insomnia
- Administration site infection
- Oesophagitis ulcerative
Indications
- Acute leukaemia
- Adrenal insufficiency
- Allergic conditions
- Anaemia
- Anal pruritus
- Ankylosing spondylitis
- Arthritis
- Aspiration pneumonitis
- Asthma
- Berylliosis
- Blood disorder
- Bursitis
- Chorioretinitis
- Choroiditis
- Colitis ulcerative
- Collagen disorder
- Conjunctivitis allergic
- Corneal ulcer marginal
- Dermatitis
- Dermatitis atopic
- Dermatitis bullous
- Dermatitis contact
- Dermatitis exfoliative
- Dermatomyositis
- Diuresis
- Drug hypersensitivity
- Eczema
- Endocrine disorder
- Endophthalmitis
- Enteritis
- Epicondylitis
- Erythema multiforme
- Erythema multiforme severe
- Erythroblastopenia
- Gastrointestinal disorder
- Gouty arthritis
- Haemolytic anaemia
- Haemorrhoids
- Herpes zoster
- Hypersensitivity
- Hypoplastic anaemia
- Idiopathic thrombocytopenic purpura
- Inflammation
- Inflammatory bowel disease
- Iridocyclitis
- Iritis
- Juvenile idiopathic arthritis
- Keratitis
- Leukaemia
- Loeffler's syndrome
- Lupus erythematosus
- Lymphoma
- Meningitis tuberculous
- Multiple sclerosis
- Mycosis fungoides
- Neoplasm malignant
- Nephrotic syndrome
- Oedema
- Ophthalmic herpes zoster
- Optic neuritis
- Osteoarthritis
- Pemphigus
- Perennial allergic rhinitis
- Pneumonia
- Polymyositis
- Posterior uveitis
- Proctitis
- Proctitis ulcerative
- Proteinuria
- Pruritus
- Psoriasis
- Psoriatic arthropathy
- Pulmonary tuberculosis
- Rash
- Rheumatic heart disease
- Rheumatoid arthritis
- Sarcoidosis
- Seborrhoeic dermatitis
- Secondary adrenocortical insufficiency
- Secondary thrombocytopenia
- Serum sickness
- Skin disorder
- Stevens-Johnson syndrome
- Sunburn
- Sympathetic ophthalmia
- Synovitis
- Systemic lupus erythematosus
- Tenosynovitis
- Thrombocytopenia
- Trichiniasis
- Ulcer
- Uremia
Subjective effects []
| 0xea / Hydrocortisone [] | |
|---|---|
Routes:
| |
Legal status []
- Australia: Hydrocortisone is a S4 / S3 / S2.
- New Zealand: Hydrocortisone is a Pharmacist only.[5]
- United Kingdom: Hydrocortisone is Prescription only / P / GSL.
- United States: Hydrocortisone is a OTC / Prescription only.[6][7][8][9][10][11][12]
- European Union: Hydrocortisone is a OTC / Prescription only.[13]
See also []
External links []
- Hydrocortisone (Wikipedia)
- Hydrocortisone (PubChem)
- Hydrocortisone (Wikidata)
- Hydrocortisone (DrugBank)
- Hydrocortisone (ChEMBL)
- Hydrocortisone (ChEBI)
- Hydrocortisone (Common Chemistry)
- Hydrocortisone (HMDB)
- Hydrocortisone (KEGG)
- Hydrocortisone (EPA DSSTox)
- Hydrocortisone (Effect Index)
- Hydrocortisone (UNII)
- Hydrocortisone (SIDER)
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5754, Hydrocortisone. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5754
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Hydrocortisone. UNII: WI4X0X7BPJ. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/WI4X0X7BPJ
Czock D, Keller F, Rasche FM, Häussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clinical Pharmacokinetics. 2005; 44(1):61–98. PMID 15634032. https://doi.org/10.2165/00003088-200544010-00003
Lennernäs H, Skrtic S, Johannsson G. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors. Expert Opinion on Drug Metabolism & Toxicology. June 2008; 4(6):749–758. PMID 18611115. https://doi.org/10.1517/17425255.4.6.749
Hydrocortisone cream. Medsafe NZ. https://www.medsafe.govt.nz/profs/datasheet/h/HydrocortisonecrAFT.pdf
Hydrocortisone Notice of enforcement policy. FDA. https://s3.amazonaws.com/archives.federalregister.gov/issue_slice/1991/8/30/43023-43026.pdf#page=3
Ala-cort- hydrocortisone cream. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de000081-a245-4f6b-9e7c-e47d84b82338
Ala-scalp- hydrocortisone lotion. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ecba1d44-33a9-44d7-ad06-13ada2375c72
Alkindi Sprinkle- hydrocortisone granule. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=26c13a5f-7119-4c6a-bf10-fda4e07d7682
Anusol HC- hydrocortisone acetate suppository. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a562f3d7-2692-4357-aade-ae50afcbfddd
Cortef- hydrocortisone tablet. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9ce19944-dd88-4a7b-84ca-b07f4ec23bad
Khindivi- hydrocortisone solution. DailyMed. 2 July 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1ef80500-8386-40ee-b608-516cd687b376
Efmody Product information. Union Register of medicinal products. https://ec.europa.eu/health/documents/community-register/html/h1549.htm
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 19:01:18 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 19:01:14 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 19:01:14 |
| gsrs | ok | 2026-11-20 19:01:15 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0000063) | 2026-11-20 19:01:14 |
| kegg | ok | 2026-11-20 19:01:17 |
| pubchem | ok | 2026-11-20 19:01:14 |
| missing (no r/tripreports posts mention it) | 2026-11-20 19:01:14 | |
| sider | ok | 2026-11-20 19:01:14 |
| structure | ok | 2026-11-20 19:01:14 |
| wikipedia | ok | 2026-11-20 19:01:15 |